Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target
| Title: | Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target |
|---|---|
| Authors: | Ferrari, Marina G.Aff1; Jimenez-Uribe, Alexis P.Aff2; Wang, LiAff3; Hoeppner, Luke H.Aff3; Murugan, PaariAff4; Hahm, EunsilAff2; Yu, JindanAff5, Aff6; Kuzel, Timothy M.Aff7; Gradilone, Sergio A.Aff8; Mansini, Adrian P.Aff1, IDs4138802302925x_cor10 |
| Source: | Oncogene. 43(7):484-494 |
| Database: | Springer Nature Journals |